MOXIFLOXACIN HYDROC

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the procurement of one package of MOXIFLOXACIN HYDROC (NSN 6505015163194) at a total price of $862.50, with an award date of July 15, 2026. The item is to be delivered FOB destination to Dyess Air Force Base, Texas, with all freight charges prepaid by the contractor and billed to the government via invoice. Inspection and acceptance will occur at the delivery point, and compliance with DFARS 252.232-7003 requires electronic invoicing through Wide Area Workflow. The procurement is administered under the DLA Troop Support Medical Supply Chain Pharm FSA and payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio. The contract utilizes the National Drug Code 68084-0722-65 and the manufacturer’s CAGE code 1XUY5, with labeling required to include the NSN, CAGE code, and line item number, though no specific packaging standards or military specifications are detailed. The acquisition is presumed to follow a Lowest Price Technically Acceptable approach, given the standardized pharmaceutical nature of the item, fixed quantity, and lack of technical evaluation criteria. No clauses from FAR or DFARS, special requirements, representations, or attachments are included in the document, and there is no indication of socioeconomic status, options, or contract type beyond its classification as a delivery order. The contractor is not required to provide size certifications or socioeconomic representations, and no contract administration personnel beyond the contracting officer, Lisa Quinn, or a local administrative contact, Shairy M. Cartagena, are formally designated. The award is sole-source with no variance allowed in quantity, and no other line items, modifications, or supplemental documents are referenced.